Oncology Marketing Trainee at Bristol-Myers Squibb

Madrid, Community of Madrid, Spain

Apply Now

Not SpecifiedCompensation

Internship, Entry Level & New GradExperience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Oncology, HealthcareIndustries

Requirements

Interest in oncology marketing and willingness to complete a 12-month traineeship in Spain and Portugal
Ability to work full-time, with onsite presence as per BMS occupancy structure (site-essential or site-by-design requiring at least 50% onsite)

Responsibilities

Collaborate in the implementation of the Annual Brand Plan
Assist in the development and creation of promotional materials: review of layouts and texts, follow-up and execution of internal approval processes for promotional materials
Participate and assist in activities and projects: contact with agencies, organization of meetings, follow-up and management of logistics
Monitor the implementation of the e-strategy / multichannel
Manage payments and contracts, process requisitions, and control budget
Collaborate with the Sales Network: handle requests for materials, send promotional cycle materials, assist in developing local plans, communications, and iPAD usage
Participate in cycle meetings: manage participants, invitations, agenda, logistics, and support innovative sessions
Support the organization and development of product team meetings

Skills

Annual Brand Plan

Materiales Promocionales

Gestión de Proyectos

e-strategy

Multichannel

Gestión de Pagos

Contratos

Control Presupuestario

Red de Ventas

Organización de Reuniones

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free